Keywords: lab21, ramps, up, kras, egfr, testing, capacity

Lab21 ramps up KRAS and EGFR testing capacity

Article | 28 July 2008

Print This

Lab21, a UK-based provider of health care diagnostic products and services, has launched K-RAS gene mutation and epidermal growth factor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in